SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-07-000113
Filing Date
2007-11-05
Accepted
2007-11-05 11:43:20
Documents
8
Period of Report
2007-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 13204
2 ex99.htm EX-99 29063
3 GRAPHIC img1.gif GRAPHIC 6791
4 GRAPHIC img2.gif GRAPHIC 9369
5 GRAPHIC img3.gif GRAPHIC 13979
6 GRAPHIC img4.gif GRAPHIC 16653
7 GRAPHIC img5.jpg GRAPHIC 1914
8 GRAPHIC img6.jpg GRAPHIC 4620
  Complete submission text file 0001367644-07-000113.txt   118049
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 071212831
SIC: 2834 Pharmaceutical Preparations